Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Materion Corporation
MTRN·Materials
B ★★★Hold
Current$285.37
Target$324.00
Return+13.5%
Aug 17, 2026

Materion is an indispensable, high-margin materials tollbooth for the AI semiconductor and defense supercycles, though its recent 160% price explosion demands patience for a better valuation entry point.

Score
83
Diageo plc
DEO·Consumer Staples
B ★★★Hold
Current$95.44
Target$109.95
Return+15.2%
Aug 16, 2026

Diageo offers a rare opportunity to acquire the world's premier portfolio of heritage spirits at a deeply distressed multiple, though investors must remain hyper-vigilant regarding the long-term impact of generational shifts in alcohol consumption and the protracted U.S. inventory correction.

Score
83
Ingram Micro Holding Corporation
INGM·Technology
B ★★★Hold
Current$28.31
Target$33.70
Return+19.0%
Aug 13, 2026

Ingram Micro is a vastly undervalued, scale-dominant tollbooth on the global AI infrastructure supercycle, successfully expanding margins through its Xvantage software platform, but public shareholders must endure a frustrating holding pattern until the massive private equity supply overhang is fully exhausted.

Score
83
Paylocity Holding Corporation
PCTY·Technology
B ★★★Hold
Current$145.67
Target$159.66
Return+9.6%
Aug 14, 2026

Paylocity is transitioning from a hyper-growth SaaS darling into a highly profitable, deeply undervalued free-cash-flow compounder, though investors must weather near-term headwinds from decelerating mid-market employment growth and shrinking interest income on client funds.

Score
83
Simpson Manufacturing Co., Inc.
SSD·Materials
B ★★★Hold
Current$198.29
Target$218.00
Return+9.9%
Aug 12, 2026

Simpson is an undisputed, highly profitable tollbooth for structural connectors with immense pricing power, though investors must remain vigilant regarding cyclical housing exposure and delayed European acquisition synergies.

Score
83
Ralliant Corporation
RAL·Technology
B ★★★Hold
Current$67.45
Target$75.44
Return+11.8%
Aug 12, 2026

Ralliant is a highly profitable, cash-generative precision technology leader riding strong electrification and defense tailwinds, though its premium multiple and inherent short-cycle industrial exposure warrant a cautious entry strategy.

Score
83
Columbia Banking System, Inc.
COLB·Financials
B ★★★Hold
Current$31.71
Target$32.76
Return+3.3%
Aug 12, 2026

Columbia Banking System is an elite, fortress-capitalized regional powerhouse poised to reap massive integration synergies and ride an impending interest rate easing cycle, though investors must remain hyper-vigilant regarding its substantial exposure to vulnerable commercial real estate markets.

Score
83
CareTrust REIT, Inc.
CTRE·Real Estate
B ★★★Hold
Current$41.22
Target$46.00
Return+11.6%
Aug 12, 2026

CareTrust is an exceptionally managed, deeply under-leveraged consolidator of the demographic 'silver economy,' though its pristine execution and aggressive pipeline are fully priced into a premium 20x forward multiple that demands absolute perfection.

Score
83
TTM Technologies, Inc.
TTMI·Technology
B ★★★Hold
Current$137.21
Target$165.00
Return+20.3%
Aug 11, 2026

TTM Technologies operates a highly lucrative, dual-engine monopoly providing mission-critical PCBs for hyperscaler AI data centers and U.S. defense systems, though investors must navigate an aggressively premium valuation that demands flawless execution of its 2026 growth mandates.

Score
83
Western Midstream Partners, LP
WES·Energy
B ★★★Hold
Current$46.83
Target$48.88
Return+4.4%
Aug 9, 2026

Western Midstream delivers compelling yield and robust free cash flow supported by Delaware Basin growth, though Occidental's massive ownership overhang structurally limits multiple expansion.

Score
83
Sun Life Financial Inc.
SLF·Financials
B ★★★Hold
Current$81.91
Target$86.80
Return+6.0%
Aug 9, 2026

Sun Life pairs a fortress-like 145% LICAT balance sheet with phenomenal structural growth in Asian bancassurance and U.S. stop-loss, yet near-term multiple expansion remains shackled by the relentless, industry-wide secular bleed of active retail equity outflows at MFS Investment Management.

Score
83
GLOBALFOUNDRIES Inc.
GFS·Technology
B ★★★Hold
Current$53.93
Target$77.00
Return+42.8%
Aug 8, 2026

GlobalFoundries is a highly profitable, geopolitically insulated specialty foundry riding the AI data center wave through its Silicon Photonics leadership, though investors must patiently navigate near-term handset cyclicality and aggressive mature-node capacity expansions from subsidized Chinese competitors.

Score
83
Joby Aviation, Inc.
JOBY·Industrials
B ★★★Hold
Current$8.58
Target$13.81
Return+60.9%
Aug 8, 2026

Joby Aviation is the most technologically advanced and heavily capitalized pioneer of the multi-billion dollar urban air mobility revolution, trading at a steep speculative premium that is justified by its impenetrable regulatory moat and imminent commercial launch catalysts.

Score
83
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
TLK·Communication Services
B ★★★Hold
Current$14.80
Target$18.35
Return+24.0%
Aug 8, 2026

Telkom Indonesia offers an impenetrable infrastructure moat and a massive 8.3% dividend yield at deeply discounted valuations, though investors must stomach sluggish core growth and persistent macroeconomic headwinds tied to its state-owned status.

Score
83
Apollo Global Management, Inc.
APO·Financials
B ★★★Hold
Current$129.74
Target$146.00
Return+12.5%
Aug 7, 2026

Apollo is the undisputed apex predator of private credit origination and permanent capital compounding, trading at a steep discount to asset-light peers, though near-term regulatory shifts (NAIC) and interest rate volatility demand patience before aggressive entry.

Score
83
Suncor Energy Inc.
SU·Energy
B ★★★Hold
Current$61.35
Target$72.60
Return+18.3%
Aug 7, 2026

Suncor is a phenomenally efficient, cash-printing integrated energy juggernaut trading at a steep discount, though investors must remain hyper-vigilant regarding the existential regulatory risk and immense capital burden of its mandatory carbon capture transition.

Score
83
IDEXX Laboratories, Inc.
IDXX·Healthcare
B ★★★Hold
Current$588.09
Target$709.14
Return+20.6%
Aug 7, 2026

IDEXX remains the undisputed, highly profitable tollbooth of the global veterinary diagnostics market, compounding value through its sticky installed base and AI-driven innovations, though investors must cautiously navigate its premium valuation multiple against a backdrop of macro-driven declines in US clinical visit volumes.

Score
83
International Flavors & Fragrances Inc.
IFF·Materials
B ★★★Hold
Current$79.29
Target$91.16
Return+15.0%
Aug 5, 2026

IFF is a deeply undervalued, wide-moat architect of the global flavor and fragrance oligopoly executing a massive balance-sheet repair, though investors must remain hyper-vigilant regarding the execution risks of its multi-billion dollar divestitures and intense margin pressure from European rivals.

Score
83
United Bankshares, Inc.
UBSI·Financials
B ★★★Hold
Current$48.45
Target$53.00
Return+9.4%
Aug 3, 2026

United Bankshares offers unmatched profitability, 52 years of dividend growth, and brilliant M&A execution, but a noticeable valuation premium relative to distressed regional peers requires investors to hold for duration rather than expect immediate, explosive multiple expansion.

Score
83
Boot Barn Holdings, Inc.
BOOT·Consumer Discretionary
B ★★★Hold
Current$148.99
Target$166.00
Return+11.4%
Aug 3, 2026

The aggressive expansion into a $58B TAM at 53% cash-on-cash returns makes Boot Barn a long-term compounding machine, but near-term vulnerability to supply chain tariffs and consumer fatigue warrants patience.

Score
83
Sumitomo Mitsui Financial Group, Inc.
SMFG·Financials
B ★★★Hold
Current$25.88
Target$28.80
Return+11.3%
Aug 3, 2026

An elite, highly efficient megabank riding historic domestic interest rate tailwinds and aggressively unlocking billions in hidden cross-shareholding value, balanced by fully-priced valuations and the looming specter of Basel III regulatory capital drag.

Score
83
DexCom, Inc.
DXCM·Healthcare
B ★★★Hold
Current$83.45
Target$100.00
Return+19.8%
Aug 2, 2026

The Stelo OTC launch and 15-day sensor upgrade provide a massive revenue compounding runway in the untapped Type 2 diabetes market, but intensifying price competition from Abbott's Libre franchise restricts multiple expansion and demands flawless execution.

Score
83
The Procter & Gamble Company
PG·Consumer Staples
B ★★★Hold
Current$143.96
Target$159.60
Return+10.9%
Aug 1, 2026

Procter & Gamble provides an impenetrable defensive moat and exceptional shareholder cash returns, yet sluggish organic volumes and margin compression limit immediate upside momentum.

Score
83
FirstEnergy Corp.
FE·Utilities
B ★★★Hold
Current$49.13
Target$54.00
Return+9.9%
Jul 31, 2026

FirstEnergy offers an ironclad 6% to 8% EPS growth floor secured by a $36 billion regulated capital plan and supercharged by a 24.8 GW data center pipeline, though it remains vulnerable to sustained high-interest rates that could compress utility valuations.

Score
83